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Abstract 
A cDNA clone for rat thromboxane (TX) A, receptor was obtained from cultured astrocytes. The cDNA encodes a protein of 341 
amino acids with seven putative transmembrane domains. The receptor is homologous with mouse and human TXA, receptors at 92.7% 
and 71.8%, respectively. Expression of messenger RNA for the receptor was examined by reverse transcriptase-polymerase chain 
reaction, showing ubiquitous expression in brain glial cells such as astrocytes, oligodendrocytes and microglia. 
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Eicosanoids play important roles not only in the periph- 
eral tissues but in the central nervous system (CNS) 111. 
Although they stimulate signal transduction pathways to 
exert their actions in the CNS [l], the distribution of the 
specific receptors in the CNS has been unclear. To know 
the expression of the eicosanoid receptors in the CNS, we 
have isolated functional cDNA clones encoding prosta- 
glandin (PG) Fza receptor [2] and PGE receptor EP, 
subtype (unpublished data) from rat astrocyte cDNA li- 
brary because the cells express several eicosanoid recep- 
tors [3]. Under the strategy, we obtained another cDNA 
clone encoding the receptor protein with the sequence 
homology to mouse thromboxane (TX) A, receptor [4]. In 
this report, we present the nucleotide sequence of the rat 
TXA, receptor and distribution of the messenger RNA 
(mRNA) in glial cells examined by reverse transcriptase- 
polymerase chain reaction (RT-PCR), since the amounts of 
RNAs from highly pure cell cultures were small and thus 
Northern blot analysis could not be performed. 
Q The nucleotide sequence reported in this paper will appear in the 
GSDB, DDBJ, EMBL, and NCBI nucleotide sequence databases with the 
accession number D32080. 
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Primary cultures of astrocytes (type-l [5]) were pre- 
pared from cerebral cortices of l-day-old Sprague-Dawley 
rat pups according to the method of Frangakis and Kimel- 
berg [6]. Experimental details and the characterization of 
cultured astrocytes were described elsewhere [7]. Microglia 
and oligodendrocytes were prepared from mixed brain cell 
cultures of newborn Wistar rats and were characterized as 
described elsewhere [8]. The cultured glial cells were 
highly pure in order to use for RT-PCR [8]. A cultured rat 
astrocyte cDNA library was constructed in the expression 
vector pEF-BOS [9] essentially as described elsewhere 
12,101. The probe DNA was 482 bp DNA fragment of 
mouse EP, receptor corresponding to regions between 
putative first and fourth transmembrane domains [ll], and 
it was labeled by a random priming method to screen 
5 . lo5 recombinants by colony hybridization under low 
stringency [2,10]. One positive clone (pFP7) contained a 
1378 bp insert (nucleotides -384 to 994 in Fig. 1) which 
encoded a partial protein homologous with mouse TXA, 
receptor. To obtain the full-length cDNA clone, 3’-end 
cDNA was amplified from rat brain cDNAs by PCR, 
essentially according to the method described by Frohman 
et al. [12] (rapid amplification of cDNA ends, RACE). The 
full-length cDNA clones were constructed from pFP7 and 
the PCR products (nucleotides 797 to 1496 with various 
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lengths of poly(A)+ tail at the 3’ end) in pBluescript KS+ 
(Stratagene). Ten independent clones were isolated and the 
both strands of the cDNAs were sequenced using ATth 
DNA polymerase sequencing kit (Toyobo Co., Japan). For 
PCR of mRNAs for rat TXA, receptor and p-actin (used 
as a control), the following oligonucleotides were designed 
as primers; TXA, receptor sense and antisense, 5’- 
TGCTGCAGACGCTACCTGTC-3’ (from 797 to 816 in 
Fig. 1) and 5’-GATI’GGCACCGTCCTTCAGG-3’ (from 
1022 to 1041 in Fig. IL); p-actin sense and antisense, 
S-GATGGTGGGTATGGGTCAGAAGGA-3’ and 5’- 
GCTCATTGCCGATAGTGATGACCT-3’ [13]. Total 
RNAs were isolated from. cultured rat astrocytes, oligoden- 
drocytes, microglia, C, glioma cells, PC12 cells, and male 
Wistar rat kidney (6 weeks) by the guanidine thiocyanate- 
acid phenol method [14]!, and the RNAs were transcribed 
into cDNAs by a random priming method. Each cDNA 
derived from 200 ng (TXA, receptor) or 20 ng ( @-actin) 
of total RNA was used as a template. The PCR was 
performed in a reaction vlolume of 50 ~1 containing dNTPs 
(200 PM), Tth DNA polymerase (2.5 U, Toyobo), 10 mM 
Tris-HCl (pH 8.91, 1.5 mM MgCl,, 80 mM KCl, 500 
pg/ml bovine serum albumin, 0.1% sodium cholate, 0.1% 
Triton X-100, and 40 pmol of primers. The PCR cycles 
consisted of denaturation at 94°C for 1 min, annealing at 
58°C for 1 min, and extension at 72°C for 2 min, for 35 
cycles (TXA, receptor) or 30 cycles ( p-actin). The num- 
bers of amplification and the amounts of cDNAs used for 
the reaction were optimized for quantitation of RNAs in 
preliminary experiments. The PCR mixtures were fraction- 
ated by 1.2% agarose gel electrophoresis in TBE buffer. 
The nucleotide sequence and the predicted amino acid 
sequence of one representative clone, RB47, which was 
constructed from pFP7 and the 3’-end RACE product, are 
shown in Fig. 1. The clone RB47 has a 1900 bp cDNA 
insert and encodes a protein of 341 amino acids with an 
estimated molecular mass of 36 860. Nine other indepen- 
dent clones have an identical sequence of inserts with that 
of RB47. The protein has seven putative transmembrane 
domains determined by the method of Kyte and Doolittle 
[15] (shown by I-VII in Fig. 1). Potential N-linked glyco- 
sylation sites exist at Asn-4 and Asn-16 in the amino acid 
terminal tail (shown by asterisks in Fig. 1). There are three 
potential phosphorylation sites by protein kinase C (Thr- 
143, Ser-144, and Thr-230, shown by arrowheads in Fig. 
l), suggesting regulation of the receptor function by pro- 
-384 GAAC*CCACTGCCT*CCGCTCCCA -361 
ACAGTOOR.OACAGGOCTCAOGAATGCAGGACCACCCCAC -271 
CTGCGCCTGTCACCCCAGCTTCAGAAGCTGGGGGC AGATOACTCTCAGGGAGTTCCAGGCCAGCCTGGTCTACACAGTCAGAGTCTGCAG -181 
GAGTGAC?TACAGAATTCCTGAGCCTTGACATTCCCAGGCCCAAAGCTCC TTGCTGCAAGGCTGTGGAACCTGATAGGGCGCAGAGACAC -91 
CAAGTGCGCCAGAOCCTOCATCAOCCCAACGTCCCAGTCAC -1 
ATGTGGCTCMCAGCACCTCGCXWXGX ATGCTTCCGCCCAGTGAACATCACGCTGCAGGAGCGACGTGCCATCGCGTCGCCATGG’ITC 90 
MWLNSTSLGACFRPVNITLQERRAIASPWF 30 
?? . I 
GCGGCATCCTTCTGCGCACTGGGCCTGGGGTCCMCCTG G;;GACCCCGCTCC 180 
AASFCALGLGSNLLALSVLAGARPGAGPRC 60 
TCCTTCC?COCTTTOCTGn;CGGCCTCGTCCTCACCOACTC 270 
SFLALLCGLVLTDFLGLLVTG AVVASOHAA 90 
II 
TTGTTGGA.Cn;GCGTOCCACTGATCCCGGTTOCCGCCTTTC 360 
LLDWRATDPGCRLCHFMGAAMVFFGLCPLL 120 
III 
CTOOGGGCtOCGATOGCTAGAGCGCTTCGTOGGCATCACAC~CCTTC~~GACCC~A~CACG~GC~C~~C~CACT 450 
LGAAMAAERFVGITRPFSRPAATSRRAWAT 
AA iv-- I50 
GTGGGGCTGGTGTGGG~ CGGGACTCTCGGGCTGCTGCCACTGCTGGGGCTCGGCCGCTACAGTGTGCAGTACCCCGGCTCCTGG 540 
VGLVWVGAGTLGLLPLLGLGRYSVQYPGSW 180 
TGCTTCT?GACTCTTGGGGCGGGACOCGOCOACOTOOCCTTCCCTC 630 
CFLTLGAGBGDVAFGLMFALLGSVSVGLSL 210 
V 
CTOCTCAACACCGTOAOCGTCCACGCTCTGCCOCGTCT 720 
L L NTVSVAT L C RVYH ARE AT Q R P RDC EVS240 
A VI 
ATOOTTCAGCTCGTAGOCATCAT~~~CCACGGTG 810 
MVO LVG I MVVATVC WMP LLVF I LOTL LO T L 270 
CCTOTCATGAGCCCCTCCGAGC~~~~ACCAC~~~C~C~TCATCTACCTAC~G~CACA-CCAGATC~G 900 
PvMSPSGQLLRTTERQLLIYLRVATWNOIL 300 
VII 
GACCCCTOGGTCTACATCCTCTTCCGTAOGTCCGTOCTTC 990 
DPWVYILFRRSVLRRLHPRFTSQLQAVSLH 330 
TCACCCCCCACACAGGCCATGCTCAGTOOACCCTOAAOOC 1080 
SPPTQAMLSGP 341 
TOTCCCAGGAGCCTGAATGlTTOOTOGGATOGAGTTACAA 1170 
GATCCTCCCTGGCCCCCTCCCCAGACTACTTGTCAGCTAGGAGGTTGGAGC ATATGTGGGAGGTCCTTGCAGGAATCTATGGTTACACAG 1260 
AGAGAACCTGoooToc CGATOGCATCTCCCATCTTGCCATAOTCCGCGTCn;TCTCCTT 1350 
TAoGcTcAAGGATcATCoOCCTToGoToTTooAAGcACCCA~~~~TAGC~TCT~AG~ACCMCCT~CGTG~ACT 1440 
GAGCCCCCTCCCCCCACGGCTATCCAACACACATGCTCiU.TAAATGGTTG8ATGTC~ 1516 
Fig. 1. Nucleotide sequence of rat thromboxane A, receptor and its deduced amino acid sequence. The sequence of one representative clone, RB47, is 
shown. The nucleotide sequence is numbered in the 5’ to 3’ direction, starting with the initiator ATG of the open reading frame. Putative N-linked 
glycosylation sites are indicated with asterisks and presumed transmembrane domains are underlined. Potential phosphorylation sites by protein kinase C 
are shown by arrowheads. A possible polyadenylation signal is double underlined. 
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tein kinase C. The clone RB47 contained a polyadenyla- 
tion signal (shown by double underline in Fig. 1) 18 bp 
upstream of a short poly(A)+ stretch of 20 residues. The 
amino acid sequence is homologous with the mouse [4] 
and human TXA, receptors [16] at 92.7% and 71.8%, 
respectively (Fig. 2). Two potential N-linked glycosylation 
sites are conserved among the three receptors, suggesting 
that addition of sugar chains to the conserved sites is an 
important step during receptor insertion into the plasma 
membrane 1171. 
As shown in Fig. 3, mRNA for TXA, receptor is 
detected in cultured astrocytes, oligodendrocytes, and mi- 
croglia as well as in kidney which is abundant in the 
mRNA [4], indicating ubiquitous expression of the mRNA 
for TXA, receptor in brain glial cells. Especially in cul- 
tured astrocytes, TXA, analog stimulates phosphoinositide 
hydrolysis, suggesting that the receptor exists in astrocytes 
[18]. The established cell lines such as C, glioma and 
PC12 cells also express the mRNA for TXA, receptor 
(Fig. 3). This is not the case in PGF,, receptor; mRNA for 
PGF,, receptor was not observed either in the two cell 
lines or in microglia under the same conditions as the 
present study (unpublished data), indicating that each 
eicosanoid has its specific role(s) in specific cell type in 
brain. P-Actin mRNA was also expressed ubiquitously in 
all samples (Fig. 3). 
In conclusion, we have cloned rat TXA, receptor cDNA 
and demonstrated that the mRNA for the receptor is 
ubiquitously expressed in brain glial cells. More recently, 
Raychowdhury et al. reported that endothelial cells ex- 
pressed another isoform of TXA, receptor with a diver- 
I 
MWLNSTSLGACFRpVNITL*ERRA&WFAASFCALGLGsNLLaLsVLA 50 
P.G 
::P.Gs...P....T....E...L...........W..A . . . . . ....................... 
50 
50 
II 
Z&GAG-PF~SFLALLCGLVLTDFLGLL~AVVASQ~ LEWRATDP 99 
..... ..-.........................I ................ 99 
. ..Q.GSHT.....TF................TI.V......FE.H.V .. 100 
Ill 
GCdLCHFMGAA"VFFGLCPLLLGMAAEF.d"G ITRPFSRPAATS-RRAW148 
S....Y...V.................S.............T...- .... 148 
... ..R...W.I....S.........S..YL..........VA.Q .... 150 
IV V 
'ATVGLVWVGAGTLGLLPLLGLG SVQYPGSWCFLTLGdGRGDVAFGLMF 198 
...... ..A..A..........................TQ....V...I. 198 
..... ..AA.LA........V...T.............GES.......L. 200 
ALLGSVSVGLSLLLNTVSVATLCF!VY~EATQ-RPRDC !di&zk247 
... ..A.....................T.....- ................ 247 
SM..GL.....F...........H...GQ..A.Q....S.....A..L .. 250 
VII 
MVVATVCW"PLLVFILQTLLQTLpVMSP QLLRTTER LLIYLRVATWN 297 
............. ..M......P....F......A..H ............ 297 
.. ..S...L......A..V.RNp.A...A...S....KE ........... 300 
QILDPWVYILFRP!SVLRRLHPRFTSQLQAVSLHSPPTQAMSGP 341 
..................... ..S........RR..A ....... 341 
........... ..A.....Q..LSTRPRSL..QPQL..RSG LQ 343 
Fig. 2. Amino acid sequence comparison of the thromboxane Azreceptors 
of various species. The deduced amino acid sequences of the rat, mouse 
[4], and human thromboxane Azreceptors [16] are aligned. Dots and 
hyphens indicate identical and deleted amino acids, respectively, com- 
pared with those of the rat. 
Fig. 3. RT-PCR analysis of mRNA for the thromboxane Azreceptor. 
Each cDNA derived from 200 ng (TXA, receptor) or 20 ng ( /%actin) of 
total RNAs was amplified using the primers described in the text. Typical 
pattern of cDNA fragments is shown. Arrows indicate the 245bp DNA 
fragment of rat thromboxane A, receptor (nucleotides 797 to 1041 in Fig. 
1) or the 630-bp DNA fragment of rat /3-actin, as ascertained by DNA 
sequencing. 
gent cytoplasmic tail, produced by alternative splicing [19]. 
However, we could not isolate a cDNA of the endothelial 
TXA, receptor isoform during 3’-RACE procedure, sug- 
gesting that the endothelial isoform is not dominant in the 
CNS. The present study will be of help in understanding 
the glial cells as a target of eicosanoids in mammalian 
CNS. 
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